Press Release FEMTO LDV Z Models: the power of one NOT TO BE RELEASED BEFORE FEBRUARY 29TH, 2012 UPDATED VERSION – PLEASE DISCARD THE PREVIOUS ONE Company Contact person Phone e-mail Web Ziemer Ophthalmic Systems AG Sandro Palumbo, Vice President Marketing +41 32 332 70 52 sandro.palumbo@ziemergroup.com www.ziemergroup.com / www.femtoldv.com Product key features  Modular platform solution – cornea and presbyopia today, cataract tomorrow1  Unique femtosecond technology with outstanding clinical results  True mobility, true efficiency Port, Switzerland; February 29th, 2012: Ziemer Ophthalmic Systems AG is pleased to announce the new femtosecond platform, the FEMTO LDV™ Z Models. FEMTO LDV Z2, Z4 and Z6 – are powerful platforms for treating a broad variety of applications in ocular surgery. The concept embraces a strategy that grows with the surgeon’s practice, offering the latest technology available today, on a platform that is ready for tomorrow. Every model is designed for an on-site upgrade; modularity makes it happen. Therefore, a seamless and stepwise upgrade between the different systems can be performed at any time. Various cornea and presbyopia treatments today, cataract options tomorrow1. With more than one and a half million operated2 eyes the FEMTO LDV is based on a proven but radically different technology. Operating at pulse frequencies in the megahertz range and with very low pulse energy, the threshold for tissue disruption is reached at very short interaction time. The advantages are excellent visual outcomes and very fast recovery. The FEMTO LDV Z Models are designed to be moved between various operating theatres. Real mobility turns the device in a multi-site universal system and supports an efficient workflow and higher productivity. The Ziemer FEMTO LDV Z Models are CE marked and available for delivery. Product launch and availability for the United States pending FDA clearance. For some countries availability may be restricted due to local registration. For further information please visit our dedicated website: www.femtoldv.com 1 The creation of a corneal pocket is part of a presbyopia intervention. Availability of related corneal inlays and implants according to policy of the individual manufacturers and regulatory status in the individual countries. Cataract procedures with the FEMTO LDV Z2, Z4 and Z6 models are not cleared in the United States and in all other countries. An upgrade possibility for these devices is planned once cataract options are available and cleared by the responsible regulatory bodies. 2 Data on file Ziemer Ophthalmic Systems AG, January 2012 /1 Ziemer Ophthalmic Systems AG Allmendstrasse 11 / CH-2562 Port, Switzerland www.ziemergroup.com / PHONE: +41 32 332 7050 / FAX: +41 32 332 7071 About Ziemer: Ziemer Ophthalmic Systems AG, a Ziemer Group Company, is a privately held company incorporated in Port, Switzerland. Founded in 1998, Ziemer Group is focused on developing, manufacturing, and marketing leading edge diagnostic and surgical ophthalmic products. Successful products developed by the group include the FEMTO LDV™ and FEMTO LDV™ Crystal Line Femtosecond Surgical Lasers, the AMADEUS® Microkeratome, the PASCAL® Dynamic Contour Tonometer and the GALILEI™ and GALILEI™ G2 Dual Scheimpflug Analyzers. Ziemer USA, Inc. is a fully owned subsidiary of Ziemer Group. It markets all Ziemer Group products in the USA. The FEMTO LDV™ Z Models will be marketed and distributed by Ziemer Ophthalmic Systems AG and its worldwide network of authorized distributors. GALILEI™, FEMTO LDV™ are trademarks, and PASCAL®, AMADEUS® and Z-LASIK® are registered trademarks of Ziemer Group Companies. /2 Ziemer Ophthalmic Systems AG Allmendstrasse 11 / CH-2562 Port, Switzerland www.ziemergroup.com / PHONE: +41 32 332 7050 / FAX: +41 32 332 7071